Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and cons
| Image |  |
|---|---|
| Description | scientific article published on 23 August 2016 |
| Author/s |
author: Paolo Marchetti Giuseppe Tonini Michelino De Laurentiis Teresa Gamucci Patrizia Vici |
| Publication date | August 23, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |